Skip to content

Q-fever Fatigue Syndrome (QFS) - a relation with upper respiratory tract infections?

Q-fever Fatigue Syndrome (QFS) - a relation with upper respiratory tract infections? - QFS - Upper respiratory tract infections

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42875
Enrollment
30
Registered
2017-04-04
Start date
2017-05-30
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronische vermoeidheid Chronic Fatigue Q fever Fatigue Syndrome

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: QFS patients (n = 10 - 15) - Meet the LCI guideline on QFS criteria for QFS - Age >= 18 - Self report of frequent upper respiratory tract infections on outpatient clinic (>= 3 upper respiratory tract infections a year).;Healthy individuals (n = 10-15) - Age >= 18

Exclusion criteria

Exclusion criteria: QFS patients (n = 10 - 15) - No use of immune suppressive medication in the past 3 months;Healthy individuals (n = 10-15) - No past Q-fever infection (serology) - No chronic Q-fever - No Q-fever vaccination - No use of immune suppressive medication in the past 3 months

Design outcomes

Primary

MeasureTime frame
1. Cytokine concentrations of monocytes ( from healthy blood donors) that were trained with C. burnetii and re-stimulated with several viral particles, and of monocytes, from QFS patients, that were stimulated with several viral particles. 2. Histone modifications surrounding the promoter regions of set cytokines, after training with C. burnetii in healthy blood donors and in QFS patients.

Secondary

MeasureTime frame
3. Outcomes of SIP and CIS questionnaires on limitations and fatigue, related to cytokine concentrations and histone modifications. 4. Clinical description of complaints / symptoms of QFS patients.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)